EC Number |
Application |
Reference |
---|
3.1.6.14 | medicine |
application of human N-acetylglucosamine 6-sulfatase, expressed in Chinese hamster ovary cells as a reversal agent for ultra-low molecular weight heparin. The enzyme removes a single 6-O-sulfo group at the non-reducing end of the ultra-low molecular weight heparin Arixtra (fondaparinux) effectively removing its ability to bind to antithrombin and preventing its inhibition of coagulation factor Xa |
729709 |
3.1.6.14 | medicine |
defect in enzyme function leads to mucopolysaccharidosis type IIID, i.e. Sanfilippo syndrome Type D |
652758 |
3.1.6.14 | medicine |
endocytosis of the recombinant enzyme by human fibroblasts |
135594 |
3.1.6.14 | medicine |
heparan sulfate storage disorder not keratan storage disorder |
135584, 135585 |
3.1.6.14 | medicine |
normal activity in patient G.G.,cell line GM 2243 |
135583 |
3.1.6.14 | medicine |
Sanfilippo D Syndrome: N-acetylglucosamine 6-sulfate sulfatase deficiency, mucopolysaccharidosis type IIID |
135582, 135586 |